Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of dehydroeburicoic acid from Antrodia camphorata in the treatment or prevention of diabetes and hyperlipidemia

Use of dehydroeburicoic acid from Antrodia camphorata in the treatment or prevention of diabetes and hyperlipidemia

US Patent 10449223 · Granted Oct 22, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of benzofuran lignans to induce IL-25 expression and suppress mammary tumor 2021
Caffeic acid derivatives for anti-angiogenesis2021
Method for treatment of hyperglycemia and hyperlipidemia2018
Method for treatment of hyperglycemia and hyperlipidemia2018
Method for treatment of hyperglycemia and hyperlipidemia2018
Method and composition for treatment or prevention of type 2 diabetes and hyperl2018
Method and composition for treatment or prevention of type 2 diabetes and hyperl2018
Method of treating or preventing hyperlipidemia with caffeamide derivatives2017
Method of treating or preventing hyperlipidemia with caffeamide derivatives2017
Method of treating or preventing hyperlipidemia with caffeamide derivatives2017
Derivatives of ergostatrien-3-β-ol from antrodia camphorata and antiglycemic, an2017
Derivatives of ergostatrien-3-β-ol from antrodia camphorata and antiglycemic, an2017